| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | 2026-09-30 | 556,000 | $4.96 | $2.76MSell |
| George Magrath | CEO | 2026-09-09 | 75,541 | $5.97 | $450.98kSell |
| George Magrath | CEO | 2026-09-09 | 392,157 | $1.15 | $450.98kBuy |
| Cam Gallagher | Director | 2026-09-08 | 784,314 | $1.15 | $901.96kBuy |
| Robert E. Gagnon | CFO | 2026-09-03 | 28,000 | $4.54 | $127.20kSell |
| Robert E. Gagnon | CFO | 2026-07-23 | 7,783 | $2.95 | $22.94kSell |
| Benjamin R. Yerxa | Pres | 2026-07-23 | 7,429 | $2.97 | $22.06kSell |
| Joseph K. Schachle | COO | 2026-07-23 | 4,644 | $2.94 | $13.65kSell |
| George Magrath | CEO | 2026-07-23 | 9,475 | $2.95 | $27.92kSell |
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | 2026-05-18 | 1,700,000 | $4.35 | $7.39MSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sungkee Chung | 196.88% | 163,800,000 | $750.20M | Insider |
| Sung Sook Park | 84.38% | 70,200,000 | $321.52M | Insider |
| Frank Ferraro | 31.25% | 26,000,000 | $119.08M | Insider |
| Inok Ahn | 16.83% | 14,000,000 | $64.12M | Insider |
| Chang Ho Ahn | 13.83% | 11,510,000 | $52.72M | Insider |
| Rexgene Biotech Co Ltd | 6.62% | 5,505,956 | $25.22M | Insider |
| Foundation Fighting Blindness Retinal Degeneration Fund | 3.89% | 3,236,171 | $14.82M | Insider |
| Cam Gallagher | 3.57% | 2,966,111 | $13.58M | Insider |
| Young Soon Park | 3.25% | 2,706,500 | $12.40M | Insider |
| George Magrath | 2.46% | 2,048,485 | $9.38M | Insider |